| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5687403 | The Journal of Urology | 2017 | 22 Pages |
Abstract
Add-on mirabegron appears to be a safe alternative for children with refractory overactive bladder. Dual therapy is well tolerated and adjusted dose regimen appears safe in this first pediatric study.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Fannie Morin, Anne-Sophie Blais, Geneviève Nadeau, Katherine Moore, Lucie Genois, Stéphane Bolduc,